Clinical Trial Update: SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme [Phase 3]

View source ↗

Summary

Phase 3 trial comparing SU-101 with procarbazine for glioblastoma multiforme has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Procarbazine (procarbazine)
• SU-101

Snippet

Sponsor: Pfizer | Conditions: Brain and Central Nervous System Tumors | Phase 3 | Status: COMPLETED